
Balancing Efficacy and Value for Cell and Gene Therapy Through Value-Based Pricing
The economics of novel cell and gene therapies present a growing challenge as these groundbreaking treatments gain traction in the health care landscape, explained Corey Cutler, MD, MPH, president of the American Society for Transplantation and Cellular …